Genera Biosystems Ltd (GBI):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Genera Biosystems Ltd (GBI) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12393
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genera Biosystems Ltd (GBL) is a multiplexed molecular diagnostic testing product developer. The company offers RTIplex and PapType molecular diagnostic test. Its RTIplex is a multiplexed and automated PCR based test for detection of viral and bacterial respiratory pathogens; and PapType is a molecular diagnostic test for the detection and genotyping of high risk and low risk types of human papillomavirus that cause cervical cancer or genital warts. GBL uses AmpaSand beads technology to create identifiable clusters of beads that can be distinguished in a conventional flow cytometer. The company provides products to detect influenzaA, influenzaB, influenza A H1N1, influenzaA H5N1, respiratory syncytial virus, human metapneumovirus, adenovirus, rhinovirus, bordetella pertussis, and chlamydophila pneumonia. It collaborates with pathology customers and IVD companies. GBL is headquartered in Melbourne, Victoria, Australia.

Genera Biosystems Ltd (GBI) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genera Biosystems Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genera Biosystems Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Equity Offering 11
Genera Biosystems Announces Private Placement of Shares for USD0.5 Million 11
Genera Biosystems Completes Private Placement Of Shares For US$0.12 Million 12
Genera Biosystems Raises USD1.01 Million in Rights Issue Of Shares 13
Debt Offering 14
Genera Biosystems Completes Private Placement of Notes for USD0.3 Million 14
Genera Biosystems Raises USD0.2 Million in Private Placement of Notes Due 2015 15
Genera Biosystems Completes Private Placement Of Notes Due 2015 For US$0.34 Million 16
Genera Biosystems Ltd – Key Competitors 17
Genera Biosystems Ltd – Key Employees 18
Genera Biosystems Ltd – Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Financial Announcements 20
Nov 01, 2018: Genera Biosystems: Quarterly cash flow & business update for 30th June 2018 20
Corporate Communications 21
Nov 30, 2018: Genera Biosystems: changes to the board of directors 21
Other Significant Developments 22
May 01, 2018: Genera Biosystems:Quarterly Cash Flow & Business Update 22
Nov 01, 2017: Genera Biosystems: Quarterly Cash Flow & Business Update 23
Jul 31, 2017: Genera Biosystems: Quarterly Cash Flow & Business Update 24
May 01, 2017: Genera Biosystems: Quarterly Cash Flow & Business Update for the period ended 31 March 2017 26
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genera Biosystems Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genera Biosystems Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Genera Biosystems Ltd, Medical Devices Deals, 2012 to YTD 2018 9
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Genera Biosystems Announces Private Placement of Shares for USD0.5 Million 11
Genera Biosystems Completes Private Placement Of Shares For US$0.12 Million 12
Genera Biosystems Raises USD1.01 Million in Rights Issue Of Shares 13
Genera Biosystems Completes Private Placement of Notes for USD0.3 Million 14
Genera Biosystems Raises USD0.2 Million in Private Placement of Notes Due 2015 15
Genera Biosystems Completes Private Placement Of Notes Due 2015 For US$0.34 Million 16
Genera Biosystems Ltd, Key Competitors 17
Genera Biosystems Ltd, Key Employees 18

List of Figures
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Genera Biosystems Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Genera Biosystems Ltd, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Genera Biosystems Ltd (GBI):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Global Franchise Group, LLC:企業の戦略・SWOT・財務情報
    Global Franchise Group, LLC - Strategy, SWOT and Corporate Finance Report Summary Global Franchise Group, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Stericycle, Inc. (SRCL):企業の財務・戦略的SWOT分析
    Stericycle, Inc. (SRCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Alabama Municipal Electric Authority:電力:M&Aディール及び事業提携情報
    Summary Alabama Municipal Electric Authority (AMEA) is a not-for-profit publicly-owned electric utility that generates, procures, and supplies power. The authority generates electricity from sources such as gas and solar. AMEA procures electricity from open market and South Carolina Public Service A …
  • Shionogi & Co Ltd (4507):企業の財務・戦略的SWOT分析
    Shionogi & Co Ltd (4507) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Avantis Medical Systems Inc:医療機器:M&Aディール及び事業提携情報
    Summary Avantis Medical Systems Inc (AMS) is a medical device company that provides visualization technology solutions. The company uses its technology platform and software analysis for the screening and early detection of cancer. It offers products such as single camera colonoscopy devices and thi …
  • Virgin Active Limited
    Virgin Active Limited - Strategy, SWOT and Corporate Finance Report Summary Virgin Active Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Sumitomo Corp (8053):電力:M&Aディール及び事業提携情報
    Summary Sumitomo Corp (Sumitomo) is a multifaceted business enterprise. It operates various businesses such as metal products, transportation, construction systems, infrastructure, media, network & lifestyle retail, general products, real estate, financial services, logistics, mineral resources and …
  • Vascular Solutions Inc-医療機器分野:企業M&A・提携分析
    Summary Vascular Solutions Inc (Vascular Solutions), a subsidiary of Teleflex Inc, is a medical device company that develops and markets clinical solutions for coronary and peripheral vascular procedures. The company’s portfolio spans various types of catheters used for simultaneous pressure measure …
  • Excelsior Gold Limited (EXG):企業の財務・戦略的SWOT分析
    Excelsior Gold Limited (EXG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • TyraTech Inc (TYR):企業の財務・戦略的SWOT分析
    Summary TyraTech Inc (TyraTech) is a clean technology and life science company that manufactures, markets, and develops insect and parasite control products. The company offers products such as equine fly spray, head lice solutions, insect repellent, insect and parasite products, and production anim …
  • OTP Bank Nyrt:企業の戦略・SWOT・財務分析
    OTP Bank Nyrt - Strategy, SWOT and Corporate Finance Report Summary OTP Bank Nyrt - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Claris Lifesciences Ltd (533288)-製薬・医療分野:企業M&A・提携分析
    Summary Claris Lifesciences Ltd (Claris) is a manufacturer of generic drugs and pharmaceutical products. The company offers generic drugs that are directly injected into the human body, which is mainly used in the treatment of critical illnesses. Its products are offered through various delivery sys …
  • PT Bumi Resources Tbk:企業のM&A・事業提携・投資動向
    PT Bumi Resources Tbk - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's PT Bumi Resources Tbk Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • FirstRand Limited (FSR):企業の財務・戦略的SWOT分析
    FirstRand Limited (FSR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Pacific Edge Ltd (PEB)-医療機器分野:企業M&A・提携分析
    Summary Pacific Edge Ltd (PEB) is a diagnostics company that discovers, develops and commercializes diagnostic tests for the early detection and monitoring of cancer. The company provides lead product such as Cxbladder, a non-invasive laboratory test for the detection of bladder cancer. It is develo …
  • Top Frontier Investment Holdings Inc:企業の戦略・SWOT・財務分析
    Top Frontier Investment Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Top Frontier Investment Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Spotlight Innovation Inc (STLT):製薬・医療:M&Aディール及び事業提携情報
    Summary Spotlight Innovation Inc (Spotlight Innovation), formerly American Exploration Corp is a developer of proprietary technologies designed to treat rare, emerging and neglected diseases. The company’s product pipeline includes drug candidates for the treatment of cancer derived from specialized …
  • Gedeon Richter Plc:企業の戦略・SWOT・財務分析
    Gedeon Richter Plc - Strategy, SWOT and Corporate Finance Report Summary Gedeon Richter Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Mediclin AG (MED):企業の財務・戦略的SWOT分析
    Summary Mediclin AG (Mediclin) is a healthcare service provider that provides rehabilitation and medical care services. The center provides services in neuro-medicine with neurology, early neurological rehabilitation, neurosurgery and neuroradiology and psychological sciences, among others. It also …
  • China International Water & Electric Corp:企業の戦略的SWOT分析
    China International Water & Electric Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆